News

Pfizer Inc. and BioNTech SE announced that, in a Phase 3 trial in adolescents 12 to 15 years of age with or without prior evidence of SARS-CoV-2 infection, the Pfizer-BioNTech COVID-19 vaccine BNT162b2 demonstrated 100% efficacy and robust antibody...

Roche announced that the Elecsys® EBV panel has launched in countries accepting the CE Mark. Roche will file for approval with the FDA in the future. The Elecsys® EBV panel consists of three immunoassays: Elecsys EBV IgM, Elecsys EBV...

CoolMed, specialists in medical refrigeration, have strengthened their product offering with the launch of theCoolMed Portable Vaccine Carrier. The carrier is designed to enable healthcare professionals to easily transport vaccines, solving the problem of cold chain compliance on the move...

Daiichi Sankyo Company, Limited announced that it has initiated in Japan a first-in-human phase 1 trial for nafamostat inhalation formulation (DS-2319), which is being developed as a potential medicine for the treatment of the novel coronavirus infectious disease (hereinafter,...

Cold Chain Technologies announced that it is partnering with B Medical Systems, a Luxembourg-based manufacturer and global distributor of medical refrigeration and durable vaccine cold-chain technology. The partnership expands Cold Chain Technologies' portfolio to include hand-carry transport solutions as...

Ajinomoto Bio-Pharma Services Cold Chain Technologies Partners with B Medical Systems , a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce a manufacturing agreement expansion with AstraZeneca to include drug product manufacturing. This agreement expands...

Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has entered into an agreement with the African Vaccine Acquisition Trust (AVAT) to make available up to 220 million doses of its single-shot COVID-19 vaccine candidate...